Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Update Il y a 4 ans
Reference: NCT00430781

Woman Man

Extract

This study is being conducted to compare the efficacy and safety of pazopanib in combination with lapatinib with that of lapatinib alone or pazopanib alone in subjects with metastatic cervical cancer


Inclusion criteria

  • Neoplasms, Uterine Cervix ,Metastatic Cervical Cancer


Links